Guinea-Bissau vs Somalia: Access to anti-retroviral drugs, male
Guinea-Bissau
62.0%
in 2024
Somalia
63.0%
in 2024
Guinea-Bissau rank
94th
Somalia rank
92nd
Access to anti-retroviral drugs, male over time
- Guinea-Bissau
- Somalia
How they compare
Somalia currently reports 63.0% against 62.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Somalia ahead.
Guinea-Bissau ranks 94th and Somalia ranks 92nd of 141 countries.
Across the 3 decades both report, Guinea-Bissau averaged higher in 1 and Somalia in 2.
Head to head by decade
| Decade | Guinea-Bissau | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 1.5% | 0.5% | Guinea-Bissau |
| 2010s | 19.4% | 23.8% | 4.4% | Somalia |
| 2020s | 48.0% | 51.0% | 3.0% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Guinea-Bissau or Somalia?
- Somalia, at 63.0% against 62.0% in Guinea-Bissau as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Guinea-Bissau and Somalia?
- 1.0%, with Somalia ahead.
- How many years of comparable data are there for Guinea-Bissau and Somalia?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea-Bissau and Somalia rank globally for access to anti-retroviral drugs, male?
- Guinea-Bissau ranks 94th and Somalia ranks 92nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.